Publications
- Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and with MDD Cyril D’Souza et al Neuropsychopharmacology (2022) 47:1854–1862.
- Exploratory Controlled Study of the Migraine Suppressing-Effects of Psilocybin Schindler, Emmanuelle A. D. Schindler et al Neuotherapeutics (2021) Jan 18(1):534-544.
News
- First study showing the Dose-Related Safety, Tolerability and Efficacy of DMT in patients with MDD published - published in 2022.
- First study showing the migraine suppressing effect of oral psilocybin - published in 2021.
